Published in Br J Cancer on March 01, 1998
Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology (1999) 3.06
The expression of mismatched repair genes and their correlation with clinicopathological parameters and response to neo-adjuvant chemotherapy in breast cancer. Int Semin Surg Oncol (2007) 1.03
A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer. Br J Cancer (2001) 1.02
The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer. Int J Colorectal Dis (2006) 0.94
Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma. World J Gastroenterol (2005) 0.83
5-fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer. Int J Colorectal Dis (2006) 0.81
Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. Am J Physiol Gastrointest Liver Physiol (2011) 0.81
Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells. Br J Cancer (2002) 0.78
The "comparative growth assay": examining the interplay of anti-cancer agents with cells carrying single gene alterations. Neoplasia (1999) 0.78
Development of a cost-effective high-throughput process of microsatellite analysis involving miniaturized multiplexed PCR amplification and automated allele identification. Hum Genomics (2013) 0.77
A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients. J Cancer Res Clin Oncol (2016) 0.75
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (1995) 13.15
Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev (1996) 9.64
Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat Biotechnol (1996) 7.94
The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol (1996) 6.62
Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell (1995) 5.54
Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res (1994) 3.63
hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci U S A (1996) 3.60
GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science (1995) 3.34
DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol (1994) 3.18
Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci U S A (1994) 3.10
An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci U S A (1993) 3.07
Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res (1994) 2.89
The role of DNA mismatch repair in platinum drug resistance. Cancer Res (1996) 2.88
The mutation rate and cancer. Proc Natl Acad Sci U S A (1996) 2.73
Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc Natl Acad Sci U S A (1996) 2.57
Identification of mismatch repair genes and their role in the development of cancer. Curr Opin Genet Dev (1995) 2.37
Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res (1995) 2.35
APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A (1996) 2.18
Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res (1995) 2.17
Energy transfer in a bioluminescent system. J Cell Physiol (1971) 2.13
Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line. J Biol Chem (1996) 2.01
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res (1996) 1.63
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res (1997) 1.50
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res (1997) 1.47
Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res (1996) 1.47
DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage. Biochemistry (1994) 1.43
The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem Biol (1996) 1.42
Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res (1997) 1.29
Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma. Cancer Commun (1990) 1.27
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells. Semin Hematol (1978) 0.97
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol (1996) 6.62
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology (1999) 3.06
The role of DNA mismatch repair in platinum drug resistance. Cancer Res (1996) 2.88
Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature (1994) 2.71
Transaxillary minithoracotomy versus video-assisted thoracic surgery for spontaneous pneumothorax. Ann Thorac Surg (1996) 2.65
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res (1999) 2.50
The role of DNA mismatch repair in drug resistance. Clin Cancer Res (1998) 2.49
Attitudes on immunization: a survey of American chiropractors. J Manipulative Physiol Ther (1995) 2.44
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells (1990) 2.43
Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res (1996) 2.37
Rapid concentration and purification of polyoma virus and SV40 with polyethylene glycol. Virology (1970) 2.37
Interexaminer reliability of eight evaluative dimensions of lumbar segmental abnormality: Part II. J Manipulative Physiol Ther (1993) 2.32
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol (1999) 2.29
Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70 C. J Bacteriol (1967) 2.29
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology (2004) 2.20
Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer (1993) 2.10
Enzymatic modification of aminoglycoside antibiotics: a new 3-N-acetylating enzyme from a Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother (1976) 2.10
Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses. J Virol (1985) 2.08
Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol (1990) 2.03
Loss of simian virus 40 DNA-RNA hybrids from nitrocellulose membranes; implications for the study of virus--host DNA interactions. Proc Natl Acad Sci U S A (1972) 2.00
Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene (1994) 1.88
Immediate reconstruction of the perineal wound with gracilis muscle flaps following abdominoperineal resection and intraoperative radiation therapy for recurrent carcinoma of the rectum. Ann Surg Oncol (1999) 1.88
Studies of morphology and immunofluorescence of Pneumocystis carinii. Proc Soc Exp Biol Med (1972) 1.82
Enzymatic modification of aminoglycoside antibiotics: a new 6'-N-acetylating enzyme from a Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother (1976) 1.81
Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer (2003) 1.80
Crystal structure of NAD(+)-dependent DNA ligase: modular architecture and functional implications. EMBO J (2000) 1.78
Enterobacter sakazakii infections in neonates associated with intrinsic contamination of a powdered infant formula. Infect Control Hosp Epidemiol (1989) 1.74
Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev (2004) 1.74
Molecular cloning and expression of a complementary DNA for inositol 1,4,5-trisphosphate 3-kinase. Science (1990) 1.70
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells. Eur J Cancer Clin Oncol (1989) 1.68
Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV). Am J Pathol (1982) 1.66
Chromosomal mapping of the mink cell focus-inducing and xenotropic env gene family in the mouse. Proc Natl Acad Sci U S A (1983) 1.65
Strongly linked current flow in polycrystalline forms of the superconductor MgB2. Nature (2001) 1.64
Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem (2000) 1.60
Needle thoracic sympathectomy for essential hyperhidrosis: intermediate-term follow-up. Ann Thorac Surg (2000) 1.60
Loss of DNA mismatch repair: effects on the rate of mutation to drug resistance. J Natl Cancer Inst (1997) 1.58
Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis. Curr Ther Res Clin Exp (1973) 1.57
cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res (1988) 1.56
The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer (2005) 1.54
Phylogenetic analysis of swine influenza viruses recently isolated in Korea. Virus Genes (2008) 1.52
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol (1993) 1.52
In vitro infection of lymphoid cells by thymotropic radiation leukemia virus grown in vitro. Proc Natl Acad Sci U S A (1975) 1.52
Ultra fast symmetry and SIMD-based projection-backprojection (SSP) algorithm for 3-D PET image reconstruction. IEEE Trans Med Imaging (2007) 1.51
Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost (2013) 1.50
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res (1997) 1.50
Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr (1973) 1.49
Defective bacteriophage PBSH in Bacillus subtilis. II. Intracellular development of the induced prophage. J Virol (1969) 1.49
Acute renal cortical necrosis caused by an antifibrinolytic drug (tranexamic acid). Nephrol Dial Transplant (1999) 1.48
Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation. Transplant Proc (2008) 1.48
Arthroscopic one-piece excision technique for the treatment of symptomatic lateral discoid meniscus. Arthroscopy (1996) 1.48
Influence of type of carbohydrate on atherosclerosis in baboons fed semipurified diets plus 0.1% cholesterol. Am J Clin Nutr (1980) 1.47
Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res (1997) 1.47
Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med (1982) 1.46
Efficacy of spinal manipulation for chronic headache: a systematic review. J Manipulative Physiol Ther (2001) 1.45
Circulating immunoglobulin complexes in Wegener's granulomatosis. Am J Med (1976) 1.43
The porcine and lagomorph septal cartilages: models for tissue engineering and morphologic cartilage research. Am J Rhinol (2001) 1.42
Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J Biol Chem (2000) 1.42
Primary structure, functional expression, and chromosomal localization of the bumetanide-sensitive Na-K-Cl cotransporter in human colon. J Biol Chem (1995) 1.40
Thioredoxin-linked "thiol peroxidase" from periplasmic space of Escherichia coli. J Biol Chem (1995) 1.40
Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. Am J Pathol (1994) 1.39
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol (1992) 1.39
Removals of hydrogen peroxide and hydroxyl radical by thiol-specific antioxidant protein as a possible role in vivo. Biochem Biophys Res Commun (1993) 1.38
[Comparative studies on the teaching of oral pathology]. Dtsch Zahnarztl Z (1976) 1.37
Catecholamine-stimulated ion transport in duck red cells. Gradient effects in electrically neutral [Na + K + 2Cl] Co-transport. J Gen Physiol (1982) 1.36
On the regulation of the initiation of DNA replication in bacteria. Cold Spring Harb Symp Quant Biol (1968) 1.35
The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transplant (2008) 1.34
Reticulum cell neoplasms induced in C57BL/6 mice by cultured virus grown in stromal hematopoietic cell lines. J Natl Cancer Inst (1979) 1.33
Analysis of the yeast arginine methyltransferase Hmt1p/Rmt1p and its in vivo function. Cofactor binding and substrate interactions. J Biol Chem (2000) 1.31
Non-thymic malignant lymphomas induced in C57BL/6 mice by cloned dualtropic viruses isolated from hematopoietic stromal cell lines. Eur J Cancer (1980) 1.31
Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res (1985) 1.30
Adherence to yoga and exercise interventions in a 6-month clinical trial. BMC Complement Altern Med (2007) 1.30
Pain, disability, and satisfaction outcomes and predictors of outcomes: a practice-based study of chronic low back pain patients attending primary care and chiropractic physicians. J Manipulative Physiol Ther (2001) 1.30
Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res (1997) 1.29
Identification of genes that mediate sensitivity to cisplatin. Mol Pharmacol (2001) 1.28
Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma. Cancer Commun (1990) 1.27
A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol (2001) 1.27
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br J Cancer (2001) 1.26
Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro. Br J Cancer (1994) 1.26
Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer. Ann Oncol (2013) 1.26
Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ (1998) 1.26
Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo. Gut (2006) 1.25
Ethnopharmacology and systems biology: a perfect holistic match. J Ethnopharmacol (2005) 1.23